BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 10, 2013
View Archived Issues
GlaxoSmithKline presents new agents for HCV infection
Read More
CLIC3 identified as a marker of breast cancer prognosis
Read More
Scientists discover a new chimeric gene associated with myeloma
Read More
First-in-human study data reported for ACE-536
Read More
Novel phosphodiesterase inhibitors patented by Nycomed (Takeda Pharmaceutical)
Read More
Basilea Pharmaceutica discloses new antibacterial agents
Read More
Boehringer Ingelheim Pharma patents new CCR2 receptor antagonists
Read More
IntraCellular Therapies prepares novel PDE1A inhibitors
Read More
Aurigene Discovery Technologies divulges novel hPD-1 inhibitors
Read More
BrainStorm's NurOwn trial is fast-tracked to phase IIa
Read More
First-in-human phase I study begins for TGR-1202
Read More
The methodology and application of a single-cell, genome-wide analysis of genetic polymorphisms
Read More
Phase I RenaZorb data support further development
Read More
Advanced Cell Technology gives update on phase I/II stem cell trials in SMD and AMD
Read More
Takara Bio begins phase I trial of HIV-1 gene therapy
Read More
Baxter reports phase III data for FEIBA NF
Read More
FDA approves Kineret for the treatment of NOMID
Read More
Tobira Therapeutics reports data from phase IIb cenicriviroc trial
Read More
Uluru begins launch of Altrazeal in Europe
Read More
Chugai and Debiopharm enter license agreement for anticancer agent
Read More
FDA and EMA to review GE Healthcare's applications for flutemetamol (18F)
Read More
Novel allergic dermatitis model in pigs reveals activity of escin
Read More
GSK and Theravance submit MAA for umeclidinium bromide/vilanterol
Read More
Bayer's Skyla approved by FDA to prevent pregnancy for up to 3 years
Read More
Takeda launches Lotriga 2 g for the treatment of hyperlipidemia in Japan
Read More
Biocon receives marketing authorization in India for itolizumab
Read More